Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer

Abstract Background With the increasing incidence of colorectal cancer (CRC), its accurate diagnosis is critical and in high demand. However, conventional methods are not ideal due to invasiveness and low accuracy. Herein, we aimed to identify efficient CRC mRNA markers in a non-invasive manner usin...

Full description

Bibliographic Details
Main Authors: Byung Seok Cha, Ki Soo Park, Jun Seok Park
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Journal of Biological Engineering
Subjects:
Online Access:https://doi.org/10.1186/s13036-020-0225-9
_version_ 1818971177894281216
author Byung Seok Cha
Ki Soo Park
Jun Seok Park
author_facet Byung Seok Cha
Ki Soo Park
Jun Seok Park
author_sort Byung Seok Cha
collection DOAJ
description Abstract Background With the increasing incidence of colorectal cancer (CRC), its accurate diagnosis is critical and in high demand. However, conventional methods are not ideal due to invasiveness and low accuracy. Herein, we aimed to identify efficient CRC mRNA markers in a non-invasive manner using CRC-derived extracellular vesicles (EVs). The expression levels of EV mRNAs from cancer cell lines were compared with those of a normal cell line using quantitative polymerase chain reaction. Eight markers were evaluated in plasma EVs from CRC patients and healthy controls. The diagnostic value of each marker, individually or in combination, was then determined using recessive operating characteristics analyses and the Mann-Whitney U test. Results Eight mRNA markers (MYC, VEGF, CDX2, CD133, CEA, CK19, EpCAM, and CD24) were found to be more abundant in EVs derived from cancer cell lines compared to control cell lines. A combination of VEGF and CD133 showed the highest sensitivity (100%), specificity (80%), and accuracy (93%) and an area under the curve of 0.96; hence, these markers were deemed to be the CRC signature. Moreover, this signature was found to be highly expressed in CRC-derived EVs compared to healthy controls. Conclusions VEGF and CD133 mRNAs comprise a unique CRC signature in EVs that has the potential to act as a novel, non-invasive, and accurate biomarker that would improve the current diagnostic platform for CRC, while also serving to strengthen the value of EV mRNA as diagnostic markers for myriad of diseases.
first_indexed 2024-12-20T14:48:14Z
format Article
id doaj.art-b711ea63619947bf826881cdef79a01f
institution Directory Open Access Journal
issn 1754-1611
language English
last_indexed 2024-12-20T14:48:14Z
publishDate 2020-02-01
publisher BMC
record_format Article
series Journal of Biological Engineering
spelling doaj.art-b711ea63619947bf826881cdef79a01f2022-12-21T19:37:04ZengBMCJournal of Biological Engineering1754-16112020-02-011411910.1186/s13036-020-0225-9Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancerByung Seok Cha0Ki Soo Park1Jun Seok Park2Department of Biological Engineering, College of Engineering, Konkuk UniversityDepartment of Biological Engineering, College of Engineering, Konkuk UniversitySchool of Medicine, Kyungpook National UniversityAbstract Background With the increasing incidence of colorectal cancer (CRC), its accurate diagnosis is critical and in high demand. However, conventional methods are not ideal due to invasiveness and low accuracy. Herein, we aimed to identify efficient CRC mRNA markers in a non-invasive manner using CRC-derived extracellular vesicles (EVs). The expression levels of EV mRNAs from cancer cell lines were compared with those of a normal cell line using quantitative polymerase chain reaction. Eight markers were evaluated in plasma EVs from CRC patients and healthy controls. The diagnostic value of each marker, individually or in combination, was then determined using recessive operating characteristics analyses and the Mann-Whitney U test. Results Eight mRNA markers (MYC, VEGF, CDX2, CD133, CEA, CK19, EpCAM, and CD24) were found to be more abundant in EVs derived from cancer cell lines compared to control cell lines. A combination of VEGF and CD133 showed the highest sensitivity (100%), specificity (80%), and accuracy (93%) and an area under the curve of 0.96; hence, these markers were deemed to be the CRC signature. Moreover, this signature was found to be highly expressed in CRC-derived EVs compared to healthy controls. Conclusions VEGF and CD133 mRNAs comprise a unique CRC signature in EVs that has the potential to act as a novel, non-invasive, and accurate biomarker that would improve the current diagnostic platform for CRC, while also serving to strengthen the value of EV mRNA as diagnostic markers for myriad of diseases.https://doi.org/10.1186/s13036-020-0225-9Colorectal cancerExtracellular vesiclemRNAVEGFCD133Non-invasive biomarker
spellingShingle Byung Seok Cha
Ki Soo Park
Jun Seok Park
Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
Journal of Biological Engineering
Colorectal cancer
Extracellular vesicle
mRNA
VEGF
CD133
Non-invasive biomarker
title Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
title_full Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
title_fullStr Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
title_full_unstemmed Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
title_short Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
title_sort signature mrna markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
topic Colorectal cancer
Extracellular vesicle
mRNA
VEGF
CD133
Non-invasive biomarker
url https://doi.org/10.1186/s13036-020-0225-9
work_keys_str_mv AT byungseokcha signaturemrnamarkersinextracellularvesiclesfortheaccuratediagnosisofcolorectalcancer
AT kisoopark signaturemrnamarkersinextracellularvesiclesfortheaccuratediagnosisofcolorectalcancer
AT junseokpark signaturemrnamarkersinextracellularvesiclesfortheaccuratediagnosisofcolorectalcancer